Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about...
-
ResMed Secures Significant Victory in Patent Fight Against New York University
-
New study shows Chronic Obstructive Pulmonary Disease (COPD) increasing globally through 2050, with 47% growth among women.
-
Justin Leong appointed Chief Product Officer, effective immediately.Katrin Pucknat appointed Chief Marketing Officer, effective immediately.Mike Fliss appointed Chief Revenue Officer, effective...
-
Year-over-year revenue grows 16%, operating profit up 5%, non-GAAP operating profit up 10%Expects to resume its share repurchase program during upcoming quarter Note: A webcast of ResMed’s conference...
-
SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2024 on Thursday,...
-
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences. Mick Farrell, chief executive officer and chair of the...
-
Year-over-year revenue grows 23%, operating profit up 8%, non-GAAP operating profit up 13%Quarterly dividend increases 9% to $0.48 per share Note: A webcast of ResMed’s conference call will be...
-
SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on...
-
Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatmentDiagnostic management platform...